Extract
The European Respiratory Society (ERS) Lung Science Conference (LSC) is the basic science conference of the ERS and it takes place every March in Estoril, Portugal. It is important to note that, particularly at this conference, there is a lot of emphasis on the inclusion and development of Early Career Members. For example, each session is chaired by one Early Career Member together with a more senior scientist; there are 40 travel bursaries to enable abstract authors to attend the conference; there is a mentorship lunch session; and every year the Early Career Member Committee (ECMC) organises a specifically dedicated Early Career Member career development session on the Saturday afternoon. Thus, there are many reasons for Early Career Members to attend this conference but, for those who could not attend, we will describe here the scientific highlights of the LSC 2019 on the topic “Mechanisms of acute exacerbation of respiratory disease”.
Abstract
The Lung Science Conference and the Sleep and Breathing Conference 2019 brought together leading experts in the field to discuss the latest cutting-edge science, as well as various career development opportunities for early career members http://bit.ly/2XNX6V6
Footnotes
Conflict of interest: I. Almendros has nothing to disclose.
Conflict of interest: N. El-Merhie has nothing to disclose.
Conflict of interest: A. Jha reports support from the EMI-GSK Programme, outside the submitted work.
Conflict of interest: H.R. Keir has nothing to disclose.
Conflict of interest: D. Lykouras reports a European Respiratory Society Fellowship in Industry award (supported by Novartis), outside the submitted work.
Conflict of interest: I. Mahmutovic Persson has nothing to disclose.
Conflict of interest: N.D. Ubags has nothing to disclose.
Conflict of interest: S. Bartel reports grants and personal fees from Bencard Allergie GmbH, outside the submitted work.
Support statement A. Jha holds a Clinical Lectureship at the University of Cambridge, which is supported jointly by the University of Cambridge Experimental Medicine Training Initiative (EMI) programme in partnership with GlaxoSmithKline (EMI-GSK) and Cambridge University Hospitals NHS Foundation Trust. S. Bartel is supported by an ERS/EU RESPIRE 3 Marie Sklodowska-Curie Fellowship from the European Respiratory Society and the European Union's H2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 713406.
- Copyright ©ERS 2019
Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.